Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
US9649362B2 · kind B2 · utility
16Cited by
78References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2015 |
| Grant date | May 16, 2017 |
| Priority date | — |
| Expiry date | Jun 10, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, inter alia, to certain peptide conjugates, and to the use of the conjugates in the treatment of a variety of diseases or disorders, including diabetes (type 1 and/or type 2) and diabetes-related diseases or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.